Medtronic Shares Outstanding 2010-2024 | MDT
Medtronic shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Medtronic shares outstanding for the quarter ending January 31, 2024 were 1.332B, a 0.02% decline year-over-year.
- Medtronic 2023 shares outstanding were 1.333B, a 1.38% decline from 2022.
- Medtronic 2022 shares outstanding were 1.351B, a 0.19% decline from 2021.
- Medtronic 2021 shares outstanding were 1.354B, a 0.21% increase from 2020.
| Medtronic Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023 | 1,333 |
| 2022 | 1,351 |
| 2021 | 1,354 |
| 2020 | 1,351 |
| 2019 | 1,358 |
| 2018 | 1,368 |
| 2017 | 1,391 |
| 2016 | 1,426 |
| 2015 | 1,109 |
| 2014 | 1,014 |
| 2013 | 1,028 |
| 2012 | 1,060 |
| 2011 | 1,082 |
| 2010 | 1,109 |
| 2009 | 1,126 |
| Medtronic Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024-01-31 | 1,332 |
| 2023-10-31 | 1,332 |
| 2023-07-31 | 1,334 |
| 2023-04-30 | 1,333 |
| 2023-01-31 | 1,332 |
| 2022-10-31 | 1,332 |
| 2022-07-31 | 1,335 |
| 2022-04-30 | 1,351 |
| 2022-01-31 | 1,350 |
| 2021-10-31 | 1,355 |
| 2021-07-31 | 1,356 |
| 2021-04-30 | 1,354 |
| 2021-01-31 | 1,356 |
| 2020-10-31 | 1,352 |
| 2020-07-31 | 1,350 |
| 2020-04-30 | 1,351 |
| 2020-01-31 | 1,352 |
| 2019-10-31 | 1,351 |
| 2019-07-31 | 1,352 |
| 2019-04-30 | 1,358 |
| 2019-01-31 | 1,353 |
| 2018-10-31 | 1,361 |
| 2018-07-31 | 1,365 |
| 2018-04-30 | 1,368 |
| 2018-01-31 | 1,354 |
| 2017-10-31 | 1,366 |
| 2017-07-31 | 1,376 |
| 2017-04-30 | 1,391 |
| 2017-01-31 | 1,383 |
| 2016-10-31 | 1,393 |
| 2016-07-31 | 1,407 |
| 2016-04-30 | 1,426 |
| 2016-01-31 | 1,422 |
| 2015-10-31 | 1,429 |
| 2015-07-31 | 1,436 |
| 2015-04-30 | 1,109 |
| 2015-01-31 | 996 |
| 2014-10-31 | 993 |
| 2014-07-31 | 1,005 |
| 2014-04-30 | 1,014 |
| 2014-01-31 | 1,010 |
| 2013-10-31 | 1,009 |
| 2013-07-31 | 1,021 |
| 2013-04-30 | 1,028 |
| 2013-01-31 | 1,021 |
| 2012-10-31 | 1,028 |
| 2012-07-31 | 1,037 |
| 2012-04-30 | 1,060 |
| 2012-01-31 | 1,060 |
| 2011-10-31 | 1,063 |
| 2011-07-31 | 1,070 |
| 2011-04-30 | 1,082 |
| 2011-01-31 | 1,078 |
| 2010-10-31 | 1,084 |
| 2010-07-31 | 1,090 |
| 2010-04-30 | 1,109 |
| 2010-01-31 | 1,109 |
| 2009-10-31 | 1,109 |
| 2009-07-31 | 1,115 |
| 2009-04-30 | 1,126 |
| 2009-01-31 | 1,122 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $106.730B | $31.227B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $185.474B | 24.35 |
| Stryker (SYK) | United States | $128.161B | 31.78 |
| Boston Scientific (BSX) | United States | $106.966B | 34.07 |
| EssilorLuxottica (ESLOY) | France | $99.574B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.648B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.127B | 29.82 |
| ResMed (RMD) | United States | $27.032B | 27.03 |
| Terumo (TRUMY) | Japan | $25.476B | 35.98 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.896B | 16.03 |
| Baxter (BAX) | United States | $20.785B | 15.16 |
| Koninklijke Philips (PHG) | Netherlands | $19.474B | 15.53 |
| Insulet (PODD) | United States | $11.711B | 61.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.741B | 0.00 |
| Demant (WILYY) | Denmark | $9.943B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.934B | 23.64 |
| BellRing Brands (BRBR) | United States | $7.285B | 39.17 |
| Lantheus Holdings (LNTH) | United States | $4.470B | 11.54 |
| Haemonetics (HAE) | United States | $4.379B | 22.40 |
| Perrigo (PRGO) | Ireland | $4.232B | 12.10 |
| GN Store Nord (GNNDY) | Denmark | $3.937B | 25.50 |
| Envista Holdings (NVST) | United States | $3.485B | 13.26 |
| Prestige Consumer Healthcare (PBH) | United States | $3.482B | 16.46 |
| QuidelOrtho (QDEL) | United States | $2.730B | 9.91 |
| Neogen (NEOG) | United States | $2.679B | 25.77 |
| Green Thumb Industries (GTBIF) | United States | $2.630B | 83.33 |
| ICU Medical (ICUI) | United States | $2.357B | 17.58 |
| TG Therapeutics (TGTX) | United States | $2.161B | 699.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.928B | 0.00 |
| Owens & Minor (OMI) | United States | $1.895B | 18.19 |
| Verano Holdings (VRNOF) | United States | $1.790B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.780B | 0.00 |
| InMode (INMD) | Israel | $1.458B | 7.55 |
| LeMaitre Vascular (LMAT) | United States | $1.437B | 47.43 |
| National Vision Holdings (EYE) | United States | $1.388B | 43.24 |
| AdaptHealth (AHCO) | United States | $1.300B | 9.78 |
| Warby Parker (WRBY) | United States | $1.287B | 0.00 |
| AtriCure (ATRC) | United States | $1.115B | 0.00 |
| MacroGenics (MGNX) | United States | $0.982B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.899B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.779B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.712B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.693B | 14.98 |
| Evolus (EOLS) | United States | $0.666B | 0.00 |
| Quanterix (QTRX) | United States | $0.613B | 0.00 |
| Jin Medical (ZJYL) | China | $0.547B | 0.00 |
| Valneva SE (VALN) | France | $0.540B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.509B | 11.02 |
| PetIQ (PETQ) | United States | $0.487B | 18.17 |
| TerrAscend (TSNDF) | Canada | $0.478B | 0.00 |
| ZimVie (ZIMV) | United States | $0.430B | 26.35 |
| OraSure Technologies (OSUR) | United States | $0.421B | 6.96 |
| Biote (BTMD) | United States | $0.417B | 3.96 |
| Aurora Cannabis (ACB) | Canada | $0.393B | 0.00 |
| Surmodics (SRDX) | United States | $0.371B | 40.11 |
| Zynex (ZYXI) | United States | $0.361B | 41.59 |
| Viemed Healthcare (VMD) | United States | $0.314B | 31.11 |
| Cerus (CERS) | United States | $0.301B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.280B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.274B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.241B | 14.70 |
| Organigram Holdings (OGI) | Canada | $0.199B | 0.00 |
| Veru (VERU) | United States | $0.193B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.192B | 0.00 |
| Omeros (OMER) | United States | $0.176B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.163B | 0.00 |
| High Tide (HITI) | Canada | $0.160B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.159B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.134B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.130B | 65.20 |
| FitLife Brands (FTLF) | United States | $0.129B | 20.74 |
| InterCure (INCR) | Israel | $0.122B | 20.54 |
| Fonar (FONR) | United States | $0.102B | 8.80 |
| Cellectar Biosciences (CLRB) | United States | $0.099B | 0.00 |
| MariMed (MRMD) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.088B | 0.00 |
| Brainsway (BWAY) | Israel | $0.084B | 0.00 |
| Safety Shot (SHOT) | United States | $0.081B | 0.00 |
| Chimerix (CMRX) | United States | $0.081B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.060B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.86 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 15.04 |
| Bright Green (BGXX) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Flora Growth (FLGC) | United States | $0.020B | 0.00 |
| Agape ATP (ATPC) | $0.020B | 0.00 | |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 72.54 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.001B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |